Abstract:Autophagy inhibition could hinder the underlying protective mechanisms in the course of tumor treatment. The advances in autophagy inhibition have driven focus on the functionalized nanoplatforms by combining the current treatment paradigms with complementary autophagy inhibition for enhanced efficacy. Furthermore, Ca2+ overload is also a promising adjuvant target for the tumor treatment by augmenting mitochondrial damage. In this view, complementary mitochondrial Ca2+ overload and autophagy inhibition were first demonstrated as a novel strategy suitable for homing in on the shortage of photodynamic therapy (PDT). We constructed biodegradable tumor-targeted inorganic/organic hybrid nanocomposites (DPGC/OI) synchronously encapsulating IR780 and Obatoclax by biomineralization of the nanofilm method, which consists of pH-triggered calcium phosphate (CP), long circulation phospholipid block copolymers 1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE)-poly(ethylene glycol) (PEG)2000-glucose (DPG). In the presence of the hydrophilic PEG chain and glucose transporter 1 (Glut-1) ligands, DPGC would become an effectively tumor-oriented nanoplatform. Subsequently, IR780 as an outstanding photosensitizer could produce increased amounts of toxic reactive oxygen species (ROS) after laser irradiation. Calcium phosphate (CP) as the Ca2+ nanogenerator could generate Ca2+ at low pH to induce mitochondrial Ca2+ overload. The dysfunction of mitochondria could enhance increased amounts of ROS. Based on the premise that autophagy would degrade dysfunctional organelles to sustain metabolism and homeostasis, which might participate in resistance to PDT, Obatoclax as an autophagy inhibitor would hinder the protective mechanism from cancer cells with negligible toxicity. Such an enhanced PDT via mitochondrial Ca2+ overload and autophagy inhibition could be realized by DPGC/OI.The Supporting Information is available free of charge at https://pubs.acs.org/doi/10.1021/acsami.1c11583.Scanning electron microscope (SEM) imaging of CP, DPGC, and DPGC/OI (Figure S1); size distribution of DPGC/OI in serum (Figure S2); FT-IR of CP, DPGC, and DSPE-PEG-glucose (Figure S3); TEM images of DPGC/OI after incubation for 0.5 h in (Figure S4A) pH 5.2 and (Figure S4B) pH 7.4, respectively; temperature curves of IR780 + NIR and DPGC/OI + NIR after 1 min laser irradiation (Figure S5); release profiles of IR780 and Obatoclax from DPGC/OI (Figure S6A,B); CLSM images of 4T1 cancer cells treated with DPGC/I at different time points (Figure S7); ROS generation in 4T1 cells after treatment with IR780 and CP/I upon laser exposure after 48 h (Figure S8); matching histogram analysis of cleaved Caspase-3 (Figure S9); live and dead images of 4T1 cells treated with different treatments for 48 h (Figure S10); histogram Individual blood analysis of mice at 15 days after different treatments (Figure S11); tumors dissected from mice after 15 days with H&E and TUNEL staining (Figure S12); H&E staining of tissues collected from mice after 15 days of different treatments, scale bar = 200 μm (Figure S13); relative volume changes (Figure S14A) and mice body weight changes in different groups (Figure S14B), data are mean ± SD, n = 5; *P < 0.05, **P < 0.01, and ***P < 0.001 vs control; photographs of tumors ex vivo in different treatment groups within 15 days (Figure S14C) (PDF)This article has not yet been cited by other publications.

Remediating Desmoplasia with EGFR‐Targeted Photoactivable Multi‐Inhibitor Liposomes Doubles Overall Survival in Pancreatic Cancer

Remediating Desmoplasia using Targeted Photo-nanomedicines: Improving Surgical and Survival Outcomes

PD‐L1 Immune Checkpoint Targeted Photoactivable Liposomes (iTPALs) Prime the Stroma of Pancreatic Tumors and Promote Self‐Delivery

Impacting Pancreatic Cancer Therapy in Heterotypic in Vitro Organoids and in Vivo Tumors with Specificity-Tuned, NIR-Activable Photoimmunonanoconjugates: Towards Conquering Desmoplasia?

Abstract B51: Photodynamic therapy modulates extracellular matrix and induces anti-tumor immune responses in an orthotopic pancreatic cancer model

Minocycline and photodynamic priming significantly improve chemotherapy efficacy in heterotypic spheroids of pancreatic ductal adenocarcinoma

Glycolysis-non-canonical Glutamine Dual-Metabolism Regulation Nanodrug Enhanced the Phototherapy Effect for Pancreatic Ductal Adenocarcinoma Treatment.

Nanoliposomes for Photodynamic Drug Delivery: A Multifaceted Approach to Overcome Chemoresistance in Pancreatic Cancer

Abstract C016: New treatment modality for pancreatic cancer-Vascular Targeted Photodynamic therapy with WST11 (Padeliporfin) combined with endovascular light delivery

Precise Photodynamic Therapy by Midkine Nanobody-Engineered Nanoparticles Remodels the Microenvironment of Pancreatic Ductal Adenocarcinoma and Potentiates the Immunotherapy.

Multifunctional Biomimetic Nanoplatform Based on Photodynamic Therapy and DNA Repair Intervention for the Synergistic Treatment of Breast Cancer

Co-Delivery of Paclitaxel Prodrug, Gemcitabine and Porphine by Micelles for Pancreatic Cancer Treatment Via Chemo-Photodynamic Combination Therapy

Dual-responsive supramolecular photodynamic nanomedicine with activatable immunomodulation for enhanced antitumor therapy

A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer

Enzyme‐Activated Prodrug‐Based Smart Liposomes Specifically Enhance Tumor Hemoperfusion with Efficient Drug Delivery to Pancreatic Cancer Cells and Stellate Cells

Sequential Delivery of Nanoformulated Α-Mangostin and Triptolide Overcomes Permeation Obstacles and Improves Therapeutic Effects in Pancreatic Cancer.

Multifunctional Nanodrug Mediates Synergistic Photodynamic Therapy and MDSCs-Targeting Immunotherapy of Colon Cancer

Modulating cancer-stroma crosstalk by a nanoparticle-based photodynamic method to pave the way for subsequent therapies

Colloidally Stabilized DSPE-PEG-Glucose/Calcium Phosphate Hybrid Nanocomposites for Enhanced Photodynamic Cancer Therapy via Complementary Mitochondrial Ca 2+ Overload and Autophagy Inhibition

GSH-responsive polymeric micelles-based augmented photoimmunotherapy synergized with PD-1 blockade for eliciting robust antitumor immunity against colon tumor

Immunofluorescence profiling of collagen subtypes is a predictor of treatment outcomes in pancreatic cancer